Bhavik Enterpris (544551)
CyclicalScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹140 |
| Market Cap | ₹285.01 Cr |
| P/E Ratio | 84.07 |
| ROCE | 8.33% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | -34.96% |
| Debt/Equity | — |
| Sales Growth | 15.97% |
| Sector | Chemicals & Petrochemicals |
Strengths
- Sales growth of 15.97% shows top-line momentum
- Latest quarter sales of ₹294 Cr against a market cap of ₹285 Cr indicates significant business scale
- ROCE of 8.33% shows the company is generating some return on capital employed
- Listing on NSE/BSE provides accessibility and potential liquidity for retail investors
Concerns
- P/E of 84.07 is extremely high while profit growth is negative at -34.96%
- Latest quarter net profit margin is only about 1.36% (₹4 Cr on ₹294 Cr sales), leaving little buffer
- Piotroski F-Score of 4/9 suggests weak overall financial health
- No dividend and missing book value, debt, and promoter holding data reduce transparency
AI Analysis
What do I see here? A chemicals trading business with a market cap of ₹285 crore, yet the latest quarter delivered only ₹4 crore of net profit on ₹294 crore of sales. That is a razor-thin margin of about 1.4%. As Graham would say, revenue is not profit, and profit is what pays the owner. At ₹140, the stock trades at a P/E of 84 times earnings. That is a rich price for a company whose profits have fallen by almost 35%. Sales grew by nearly 16%, but I cannot ignore that the bottom line is shrinking while the multiple is expanding. That is a dangerous combination. The ROCE is just 8.33%, which offers little premium above a risk-free return, and the Piotroski score of 4 out of 9 tells me the financial fundamentals are weak. There is no dividend, so the investor depends entirely on price appreciation. In a trading business, where barriers to entry are low and margins are thin, I look for scale, pricing power, or a durable cost advantage. I see none of that here. The PEG ratio of 5.26 suggests that even if growth continues, the valuation already prices in a great deal of optimism. This looks like a cyclical trading company being valued like a fast grower. I would need a much larger margin of safety before considering an investment. At 84 times earnings with falling profits, patience is wiser than participation.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer